Cipla Limited: Generic Manufacturer

Cipla Limited represents a big pharmaceutical company from India specializing in manufacturing of more than 1,500 medications as well as some inexpensive and trustworthy generic meds for treatment of Erectile Dysfunction (ED). The products based on sildenafil, such as Suhagra and Silagra along with products based on tadalafil, such as Erectalis FC and Tadacip are predominantly sold in domestic market and also in some international online pharmacies with price ranging within $0.20 – $1.00 per tablet. Cipla also produces non-branded generic medications based on tadalafil and sildenafil for the market in western countries. Topical, oral, and injectable versions of their testosterone medications are utilized for treatment of ED in patients suffering from testosterone deficiency. In addition, medications by Cipla are applied in treatment of HIV/AIDS, various urological and respiratory conditions and others.

CIPLA LIMITED: Key Producers of Generic ED Drugs

As a massive pharma firm with more than 80 years of experience, Cipla Limited attests that generic ED drugs market is not kept for small players that produce goods of doubtful quality. That Indian corporation with headquarters situated in the heart of Mumbai and representative offices across 100 over countries around the globe produces more 1,500 medications at the moment, with 250 drugs being developed inside Cipla company itself. Cipla’s meds are sold in more than 80 countries where they are permitted by local healthcare authorities together with the UK MHRA, US FDA, MCC of South Africa, TGA of Australia and others. International sales constitute around 53% of Cipla’s annual revenue of USD 2.2B.

Cipla’s employees reach up to 25,000 people in India and around the world. At the moment, this company is listed on Bombay Stock Exchange as well as the Indian National Stock Exchange.

Right now, Cipla owns patents of 24 pharmaceutical products, which proves that replication of other companies’ medications is far not all that its scientists can do. Its drugs are applied for HIV, cancer, hepatitis, diabetes, and malaria therapies, and also in dermatology, urology, ophthalmology and other areas.

Interestingly, Cipla’s present success is attained with help pf anti-impotence drugs that the father of Cipla’s existing chairman imputed to India from Germany back in the 1930s. The medicine called Okasa had such impressive sales that it helped Hamied family to earn sufficient amount of funds to found their own pharmaceutical producing company in 1935. Presence of Cipla in ED treatment market stays firm even though it is no longer essential for the company. In article below we will discuss generic ED meds produced by Cipla Limited and marketed around the globe nowadays. It contains both general PDE-5 inhibitors such as tadalafil and sildenafil, as well as meds applied for treatment of testosterone deficiency among men. In addition, other crucial medications produced by Cipla will be also discussed and analysed in terms of their impact on the global pharma market.

author: dr. Francis Cooper